泰地罗新注射液对猪传染性胸膜肺炎的临床疗效试验  

Clinical Effect of Tildipirosin Injection on Porcine Infectious Pleuropneumonia

作　　者：贾兴[1,2] 张星 张沛 耿智霞[1,2] 瞿红颖 宋婷婷[1,2] 刘静 郭李珉 刘欣[1,2] 曹兴元 JIA Xing;ZHANG Xing;ZHANG Pei;GENG Zhi-xia;QU Hong-ying;SONG Ting-ting;LIU Jing;GUO Li-min;LIU Xin;CAO Xing-yuan(Hebei Yuanzhoang Phamaceutical Co.,Ltd,Shijiazhuang 050041,China;Hebei Technology Innovation Center of Veterinary Drugs,Shijiazhuang 050041,China;China Agricultural University,Beijing 100083,China)

机构地区：[1]河北远征药业有限公司,石家庄050041 [2]河北省兽药技术创新中心,石家庄050041 [3]中国农业大学,北京100083

出　　处：《中国兽药杂志》2022年第7期54-59,共6页Chinese Journal of Veterinary Drug

摘　　要：将泰地罗新注射液分为高、中、低(8、4、2 mg/kg bw)3个剂量组分别肌内注射治疗猪传染性胸膜肺炎,同时设默沙东动物保健品有限公司的泰地罗新注射液为对照组,按4 mg/kg bw给药,给药一次。结果表明,泰地罗新注射液中(4 mg/kg bw)、高(8 mg/kg bw)剂量对人工感染传染性胸膜肺炎病猪的有效率和治愈率无显著差异(P>0.05),与默沙东动物保健品有限公司生产的泰地罗新注射液推荐剂量(4 mg/kg bw)的效果相当。试验表明泰地罗新注射液按一次量,每1 kg体重4 mg肌注,对猪传染性胸膜肺炎有良好的治疗效果。Tildipirosin injection was divided into three groups of high,medium and low doses(8,4,2 mg/kg bw)for the treatment of porcine infectious pleuropneumonia by intramuscular injection.Meanwhile,tildipirosin injection from MSD animal health products Co.,Ltd was set as the control group,and was given 4 mg/kg bw once.The results showed that there was no significant difference in the effective rate and cure rate between medium(4 mg/kg bw)and high(8 mg/kg bw)doses of tildipirosin injection in artificially infected pigs with infectious pleuralpneumonia(P>0.05),which was similar to the recommended dose of MSD products(4 mg/kg bw).The results showed that tildipirosin injection has a good therapeutic effect on porcine infectious pleuropneumonia by intramuscular injection of 4 mg per 1 kg body weight.

关 键 词：泰地罗新注射液 猪 传染性胸膜肺炎 临床疗效 

分 类 号：S859.796[农业科学—临床兽医学]